Publications by authors named "N A Maskell"

Introduction: Secondary spontaneous pneumothorax (SSP) is a medical emergency where the lung collapses in the presence of underlying chronic lung disease. Current international clinical guidelines advise intercostal drain (ICD) insertion for SSP. However, in a previous small study needle aspiration (NA) has been shown to reduce length of hospital stay (LOHS) and reduce complications.

View Article and Find Full Text PDF
Article Synopsis
  • Medical thoracoscopy (MT) is a less invasive procedure widely accepted for diagnosing and managing pleural diseases, offering advantages for patients who cannot undergo general anesthesia.
  • Recent advancements include new techniques for identifying malignant pleural effusions and the potential benefits of combining MT with talc poudrage and pleural catheter insertion to reduce hospital stays.
  • The review discusses MT's role in treating a range of conditions beyond malignant effusions, including pneumothorax and pleural infections, highlighting its benefits and drawbacks compared to traditional methods for better clinical decision-making.
View Article and Find Full Text PDF

Background: Pleural disease is common, representing 5% of the acute medical workload, and its incidence is rising, partly due to the ageing population. Frailty is an important feature and little is known about disease progression in patients with frailty and pleural disease. We aimed to examine the effect of frailty on mortality and other relevant outcomes in patients diagnosed with pleural disease.

View Article and Find Full Text PDF

The incidence of non-malignant pleural effusions far outweighs that of malignant pleural effusions and is estimated to be at least 3-fold higher. These so-called benign effusions do not follow a "benign course" in many cases, with mortality rates matching and sometimes exceeding those of malignant pleural effusions. In addition to the impact on patients, healthcare systems are also significantly affected, with recent US epidemiological data demonstrating that 75% of resource allocation for pleural effusion management is spent on non-malignant pleural effusions (excluding empyema).

View Article and Find Full Text PDF